7.85
0.29 (3.84%)
0.29 (3.84%)
Upgrade to Real-Time
Regular Market
Low
3.86
High
15.00
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gamida Cell Ltd | GMDA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.29 | 3.84% | 7.85 | 12:55:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.58 | 7.43 | 7.85 | 7.56 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.82 | 7.86 | 0.04 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 812 | 90,738 | $ 7.65 | $ 694,245 | 900,147 | 3.86 - 15.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:56:23 | 19 | $ 7.82 | USD |
Gamida Cell Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 388.35M | 49.47M | 36.50M | $ - | $ - | -1.81 | -5.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Gamida Cell News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMDA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.05 | 8.15 | 7.1301 | 7.53 | 260,897 | -0.20 | -2.48% |
| 1 Month | 7.89 | 8.52 | 7.1301 | 7.90 | 294,968 | -0.04 | -0.51% |
| 3 Months | 7.88 | 15.00 | 7.1301 | 10.19 | 875,213 | -0.03 | -0.38% |
| 6 Months | 5.40 | 15.00 | 4.81 | 9.62 | 781,485 | 2.45 | 45.37% |
| 1 Year | 4.17 | 15.00 | 3.86 | 8.26 | 539,137 | 3.68 | 88.25% |
| 3 Years | 8.30 | 15.41 | 2.60 | 8.15 | 236,424 | -0.45 | -5.42% |
| 5 Years | 8.30 | 15.41 | 2.60 | 8.15 | 236,424 | -0.45 | -5.42% |
Gamida Cell Description
| Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients. |
